Elite Pharmaceuticals, Inc. – OTC:ELTP

Elite Pharmaceuticals stock price today

$0.575
+0.01
+3.08%
Financial Health
0
1
2
3
4
5
6
7
8
9

Elite Pharmaceuticals stock price monthly change

+212.08%
month

Elite Pharmaceuticals stock price quarterly change

+212.08%
quarter

Elite Pharmaceuticals stock price yearly change

+296.45%
year

Elite Pharmaceuticals key metrics

Market Cap
39.08M
Enterprise value
12.02M
P/E
2.95
EV/Sales
0.36
EV/EBITDA
1.43
Price/Sales
0.90
Price/Book
0.99
PEG ratio
0.04
EPS
N/A
Revenue
43.23M
EBITDA
7.89M
Income
6.80M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
21.76%
Oper. margin
14.81%
Gross margin
48.69%
EBIT margin
14.81%
EBITDA margin
18.26%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Elite Pharmaceuticals stock price history

Elite Pharmaceuticals stock forecast

Elite Pharmaceuticals financial statements

Elite Pharmaceuticals, Inc. (OTC:ELTP): Profit margin
Dec 2021 8.97M 2.28M 25.44%
Mar 2022 7.67M 2.42M 31.66%
Mar 2023 8.64M -1.22M -14.22%
Mar 2024 17.94M 3.32M 18.53%
Elite Pharmaceuticals, Inc. (OTC:ELTP): Debt to assets
Sep 2022 50343250 23.15M 45.99%
Dec 2022 52716134 22.54M 42.76%
Mar 2023 40896018 11.93M 29.19%
Mar 2024 83653536 26.07M 31.17%
Elite Pharmaceuticals, Inc. (OTC:ELTP): Cash Flow
Dec 2021 3.03M -82.07K -153.86K
Mar 2022 1.60M -264.17K -94.24K
Mar 2023 2.96M -536.21K -12.50M
Mar 2024 2.05M -403.64K -361.44K

Elite Pharmaceuticals alternative data

Elite Pharmaceuticals, Inc. (OTC:ELTP): Employee count
Aug 2023 53
Sep 2023 53
Oct 2023 53
Nov 2023 53
Dec 2023 53
Jan 2024 53
Feb 2024 53
Mar 2024 53
Apr 2024 53
May 2024 53
Jun 2024 53
Jul 2024 53

Elite Pharmaceuticals other data

Elite Pharmaceuticals, Inc. (OTC:ELTP): Insider trades (number of shares)
Period Buy Sel
Apr 2015 0 85530
Nov 2015 0 150000
Jan 2016 0 115000
Feb 2016 0 995334
Mar 2016 0 570520
Transaction Date Insider Security Shares Price per share Total value Source
Option
HAKIM NASRAT A director, 10 perc.. Common Stock 142,857,143 N/A N/A
Option
HAKIM NASRAT A director, 10 perc.. Series I Convertible Preferred Shares 100 N/A N/A
Sale
TREPPEL JERRY other: former Chairman
Common Stock 258,090 N/A N/A
Sale
TREPPEL JERRY other: former Chairman
Common Stock 312,430 N/A N/A
Sale
TREPPEL JERRY other: former Chairman
Common Stock 100,456 N/A N/A
Sale
TREPPEL JERRY other: former Chairman
Common Stock 100,000 N/A N/A
Sale
TREPPEL JERRY other: former Chairman
Common Stock 50,000 N/A N/A
Sale
TREPPEL JERRY other: former Chairman
Common Stock 24,400 N/A N/A
Sale
TREPPEL JERRY other: former Chairman
Common Stock 349,660 N/A N/A
Sale
TREPPEL JERRY other: former Chairman
Common Stock 45,518 N/A N/A
Thursday, 26 December 2024
newsfilecorp.com
Monday, 2 December 2024
newsfilecorp.com
Monday, 25 November 2024
zacks.com
Monday, 18 November 2024
zacks.com
newsfilecorp.com
Saturday, 16 November 2024
seekingalpha.com
Thursday, 14 November 2024
newsfilecorp.com
Thursday, 7 November 2024
newsfilecorp.com
Thursday, 10 October 2024
newsfilecorp.com
Monday, 7 October 2024
newsfilecorp.com
Tuesday, 27 August 2024
newsfilecorp.com
Friday, 16 August 2024
zacks.com
Thursday, 15 August 2024
seekingalpha.com
Wednesday, 14 August 2024
newsfilecorp.com
Friday, 9 August 2024
newsfilecorp.com
Friday, 12 July 2024
zacks.com
Tuesday, 2 July 2024
seekingalpha.com
zacks.com
Monday, 1 July 2024
newsfilecorp.com
Wednesday, 26 June 2024
newsfilecorp.com
Thursday, 13 June 2024
investorplace.com
Monday, 20 May 2024
accesswire.com
Thursday, 15 February 2024
seekingalpha.com
Wednesday, 14 February 2024
Accesswire
Thursday, 8 February 2024
Accesswire
Monday, 4 December 2023
InvestorPlace
Friday, 17 November 2023
Seeking Alpha
Tuesday, 14 November 2023
Accesswire
Friday, 10 November 2023
Accesswire
Monday, 9 October 2023
InvestorPlace
  • What's the price of Elite Pharmaceuticals stock today?

    One share of Elite Pharmaceuticals stock can currently be purchased for approximately $0.57.

  • When is Elite Pharmaceuticals's next earnings date?

    Unfortunately, Elite Pharmaceuticals's (ELTP) next earnings date is currently unknown.

  • Does Elite Pharmaceuticals pay dividends?

    No, Elite Pharmaceuticals does not pay dividends.

  • How much money does Elite Pharmaceuticals make?

    Elite Pharmaceuticals has a market capitalization of 39.08M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 99.83% to 56.63M US dollars.

  • What is Elite Pharmaceuticals's stock symbol?

    Elite Pharmaceuticals, Inc. is traded on the OTC under the ticker symbol "ELTP".

  • What is Elite Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.

  • How do i buy shares of Elite Pharmaceuticals?

    Shares of Elite Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Elite Pharmaceuticals's key executives?

    Elite Pharmaceuticals's management team includes the following people:

    • Mr. Nasrat Hakim Chairman, Chief Executive Officer & Pres(age: 64, pay: $1,080,000)
    • Mr. Douglas Plassche Executive Vice President of Operations(age: 61, pay: $348,540)
  • How many employees does Elite Pharmaceuticals have?

    As Jul 2024, Elite Pharmaceuticals employs 53 workers.

  • When Elite Pharmaceuticals went public?

    Elite Pharmaceuticals, Inc. is publicly traded company for more then 27 years since IPO on 23 Jul 1998.

  • What is Elite Pharmaceuticals's official website?

    The official website for Elite Pharmaceuticals is elitepharma.com.

  • Where are Elite Pharmaceuticals's headquarters?

    Elite Pharmaceuticals is headquartered at 165 Ludlow Avenue, Northvale, NJ.

  • How can i contact Elite Pharmaceuticals?

    Elite Pharmaceuticals's mailing address is 165 Ludlow Avenue, Northvale, NJ and company can be reached via phone at +20 17502646.

Elite Pharmaceuticals company profile:

Elite Pharmaceuticals, Inc.

elitepharma.com
Exchange:

OTC

Full time employees:

43

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand, as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX, an immediate release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the brand Loxapine; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company is developing a range of abuse deterrent opioid products. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey.

165 Ludlow Avenue
Northvale, NJ 07647

CIK: 0001053369
ISIN: US28659T2006
: